Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD

Part of paid clinical trials in Sacramento, California.

Sponsor
Retinal Consultants Medical Group
Study ID
NCT00426998
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
55 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this research study is to compare different timing therapies of Verteporfin with Bevacizumab to treat choroidal neovascularization (CNV) due to age-related macular degeneration (AMD).

Key Dates

Start date
Apr 30, 2006
Status verified
Jan 2007

Study Design

Enrollment
30 participants
Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT

Primary Outcome Measure

percentage of patients losing 3 or more lines of visual acuity

Locations (1)

FacilityCityStateZIPSite coordinators
Retinal Consultants Medical Group, Inc.SacramentoCalifornia95819-

Find similar trials in Sacramento, CA

By condition
Age-related macular degeneration
By specialty
OphthalmologyRetina
By research site
Retinal Consultants Medical Group, Inc.· Sacramento, CA

Related Studies